Table 4.
Study Group | |
Follow-up (weeks) | |
Min | 6 |
Max | 238 |
Mean | 54 |
Median | 37 |
Survival at last follow-up (%) | 10 (32) |
Time to Death | |
Min | 6 |
Max | 142 |
Mean | 32 |
Median | 25 |
Local disease outcome | |
Disease regression (%) | 5 (16) |
Stable disease (%) | 18 (58) |
Disease progression (%) | 8 (26) |
Death due to treated disease (%) | 0 (0) |
Time to local progression (weeks) | |
Min | 5 |
Max | 230 |
Mean | 47 |
Median | 24 |